Ellevest Inc’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Ellevest Inc’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14	Closed	–	–	1674
2021 Q2	$0	Buy	+14	New	+$97	﹤0.01%	1480

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ellevest Inc's AVEO Position: Q3 2021 in Review

Ellevest Inc sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q3 2021, closing a stake of 14 shares.

Ellevest Inc first reported a position in AVEO in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 52 funds tracked by Wall St. Rank hold AVEO as of Q3 2021.

Ellevest Inc reported no remaining AVEO Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Ellevest Inc sold 14 AVEO Pharmaceuticals, Inc. shares in Q3 2021.
Ellevest Inc first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
Ellevest Inc's AVEO Pharmaceuticals, Inc. position peaked at $0 in Q2 2021.
52 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q3 2021.

Based on Ellevest Inc's 13F filing for Q3 2021, filed 19 Oct 2021.